Skip to content

Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda

Dr Mark Siedner (top right) presenting to CROI 2021.

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

Professor Nicholas Paton (bottom, left) presenting to CROI 2021.

Ten-year Italian study shows that people with HIV remain undetectable for 97% of the time

Domizia Salusest | www.domiziasalusest.com

Near point-of-care viral load tests slash waiting times in seven African countries

Haba Pokpa, MSF Lab Technician in the MSF supported laboratory in Matam health centre, Conakry, Guinea captures results from GeneXpert tests. Image by Albert Masais/MSF.

South Africans continued to receive ART during COVID-19 lockdown, but HIV testing and starting ART were impeded

Image by PWRDF. Creative Commons licence.

Baltic neighbour states far apart on HIV prevention

Marco Verch. Creative Commons licence.

HIV self-testing increases uptake of HIV testing, but with poorer linkage to care

Domizia Salusest | www.domiziasalusest.com

Dried blood spots have clear advantages over mini tubes when it comes to lab analysis of home collected samples for HIV and syphilis testing

Image: Domizia Salusest | www.domiziasalusest.com

US HIV infections could drop by 94% before 2030, if treatment is prioritised

Image: pixinoo/Shutterstock.com/Pexels